Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07730346) titled 'Study to Assess the Prophylactic Efficacy and Safety of Sebaloxavir Marboxil Tablets/Oral Suspension for Influenza Prevention in Household Contacts Aged =2 Years' on July 23.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Triple (Participant, Care Provider, Investigator).
Primary Sponsor: Nanjing Zenshine Pharmaceuticals
Condition:
Influenza Prevention
Intervention:
Drug: Sebaloxavir marboxil
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: November 7, 2026
Target Sample Size: 858
...